Avid Bioservices Company Overview
About Avid Bioservices
Avid Bioservices (NASDAQ:CDMO) specializes in biologics contract development and manufacturing organization (CDMO) services, focusing on biopharmaceutical drug development and commercialization. This entails a range of activities from process development to clinical and commercial drug substance manufacturing, packaging, and labeling. Avid's principal objective is to support biotech and pharmaceutical companies in bringing their innovative treatments to market efficiently and cost-effectively, leveraging its state-of-the-art facilities and deep expertise in the field. With a commitment to quality, compliance, and customer satisfaction, Avid plays a crucial role in the rapidly evolving biopharma industry, adapting to meet the ever-changing needs of its global client base.
Snapshot
Operations
Products and/or services of Avid Bioservices
- Biomanufacturing services for clinical and commercial stages of biologics, including monoclonal antibodies and recombinant proteins.
- Process development services, offering cell line, upstream, and downstream process development.
- cGMP (Current Good Manufacturing Practices) manufacturing, including both drug substance and drug product under strict quality control.
- Analytical and quality control testing services, ensuring products meet regulatory and customer standards.
- Regulatory support services, guiding clients through the complexities of regulatory submissions and compliance.
- Cell line development services, utilizing cutting-edge technologies to develop high-yielding cell lines.
Avid Bioservices executive team
- Mr. Nicholas Stewart Green B.Sc., MBAPresident, CEO & Director
- Mr. Daniel R. HartChief Financial Officer
- Mr. Richard A. RichieriChief Operations Officer
- Mr. Mark R. Ziebell J.D.VP, General Counsel & Corporate Secretary
- Mr. Matthew R. KwietniakChief Commercial Officer